Low-Dose Aspirin and Pancreatic Cancer Risk-Letter

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1154. doi: 10.1158/1055-9965.EPI-17-0115. Epub 2017 Jun 20.

Authors

Theodore M Brasky^{1

2}, Jean Wactawski-Wende³

Affiliations

¹ The Ohio State University-James Comprehensive Cancer Center, Columbus, Ohio. Theodore.Brasky@osumc.edu.
² The Ohio State University College of Medicine, Division of Cancer Prevention and Control, Columbus, Ohio.
³ The State University of New York at Buffalo, School of Public Health and Health Professions, Buffalo, New York.

PMID: 28634188
DOI: 10.1158/1055-9965.EPI-17-0115

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Aspirin*
Humans
Pancreas
Pancreatic Neoplasms*
Risk

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin